ZNTL Archived Articles
Zentalis Pharmaceuticals (NASDAQ:ZNTL): A Clinical-Stage Oncology Player Navigating a Challenging Landscape
Published on March 14, 2025
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL): A Promising Oncology Pipeline Backed by Robust Financials
Published on September 24, 2024